Proteus Int PLC - Doc reMerger with Therapeutic
20 Agosto 1999 - 8:16AM
UK Regulatory
RNS No 3029e
PROTEUS INTERNATIONAL PLC
Document Re Proposed Merger
Proposed Merger with Therapeutic Antibodies Inc and Placing
0f 23,325,000 New Ordinary Shares at 40p per share by WestLB Panmure
Sponsored by Deloitte & Touche Corporate Finance
Proposal to rename the Company Protherics PLC on Completion of the
Merger
A copy of the above is available for inspection from the Company
Announcements office of the Stock Exchange, London.
END
DOCALLVITIIIFAA
Becket Invest (LSE:TAB)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Becket Invest (LSE:TAB)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024